Evidence map›Paper›PMID 40395974›Full record

ArticleJAC-antimicrobial resistance2025

Current status and future direction of antimicrobial stewardship programs and antibiotic prescribing in primary care hospitals in Zambia.

Faustina Makiko, Aubrey Chichonyi Kalungia, Martin Kampamba, Steward Mudenda, Natalie Schellack, Johanna Catharina Meyer, Flavien Nsoni Bumbangi, Michael Okorie, David Banda, Derick Munkombwe and 15 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Faustina MakikoDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Aubrey Chichonyi KalungiaDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID https://orcid.org/0000-0003-2554-1236
Martin KampambaDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Steward MudendaDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID https://orcid.org/0000-0003-1692-8981
Natalie SchellackDepartment of Pharmacology, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0000-0001-9690-6285
Johanna Catharina MeyerDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.
Flavien Nsoni BumbangiSchool of Medicine, Eden University, P.O. Box 37727, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-0731-3558
Michael OkorieBrighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
David BandaFaculty of Health Sciences, Chreso University, P.O. Box 37178, Lusaka, Zambia.
Derick MunkombweDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Ilunga MutwaleKanyama Level-1 Hospital, Ministry of Health, P.O. Box 30027, Lusaka, Zambia.
Joseph Yamweka ChizimuAntimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Stand 1186, Lusaka, Zambia.
Maisa Anita KasangaDepartment of Microbiology, University Teaching Hospitals-Adult Hospital, Private Bag RW 1X, Lusaka, Zambia.ORCID https://orcid.org/0000-0003-1724-7934
Freddie MasaningaZambia Country Office, World Health Organization, P.O. Box 32346, Lusaka, Zambia.
Zoran MuhimbaDepartment of Pathology, University Teaching Hospitals, Private Bag RW 1X, Lusaka, Zambia.
Chileshe LukwesaAntimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Stand 1186, Lusaka, Zambia.
Duncan ChandaDepartment of Internal Medicine, University Teaching Hospitals-Adult Hospital, Private Bag RW 1X, Lusaka, Zambia.ORCID https://orcid.org/0000-0001-5477-9054
Raphael ChandaAction Against Antimicrobial Resistance (ReAct) Africa, Lusaka, Zambia.
Mirfin MpunduAction Against Antimicrobial Resistance (ReAct) Africa, Lusaka, Zambia.
Chiluba MwilaDepartment of Pharmacy, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID https://orcid.org/0000-0003-0160-1222
Anja St Claire-JonesPharmacy Department, Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK.
Melanie NewportBrighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
Roma ChilengiAntimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Stand 1186, Lusaka, Zambia.
Israel Abebrese SefahPharmacy Practice Department, University of Health and Allied Sciences, Volta Region, Ghana.ORCID https://orcid.org/0000-0001-6963-0519
Brian GodmanDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.

Funding

Vanderbilt-Zambia Cancer Research Training Program (VZCARE)D43CA270474 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOUGLAS CORBETT HEIMBURGER, Wilbroad Mutale · 2022 to 2026
$1.3M
NCI NIH HHS D43 CA270474World Health Organization 001
6 · The paper itself

Abstract

Background: Antimicrobial Stewardship Programs (ASPs) intended to optimize antibiotic use will be more effective if informed by the current status and patterns of antibiotic utilisation. In Zambia's primary healthcare (PHC) settings, data on ASPs and antibiotic utilisation were inadequate to guide improvements. As a first step, this study assessed antibiotic prescribing and ASP core elements among PHC first-level hospitals (FLHs) in Zambia. Methods: A point prevalence survey was conducted at the five FLHs in Lusaka using the Global-PPS Results: Antibiotic use prevalence was 79.8% (146/183). A total of 220 antibiotic prescription encounters were recorded among inpatients, with ceftriaxone (J01DD04, Watch) being the most (50.0%) prescribed. Over 90.0% (202) of the antibiotic prescriptions targeted suspected community-acquired infections, but only 36.8% (81) were compliant with national treatment guidelines. ASP core element implementation was 36.0% (16.2/45), with only two hospitals achieving over 50.0%. The most deficient core elements were accountability, action, tracking, and reporting. Conclusions: ASP implementation in Zambia's FLHs providing PHC was sub-optimal, with high antibiotic prescribing rates, frequent use of broad-spectrum Watch group antibiotics, and low compliance with national treatment guidelines. As key ways forward, ASPs in Zambia's PHC require strengthening by adapting the WHO AWaRe recommendations and improving accountability, actions, tracking, and reporting antibiotic use to improve stewardship practice and reduce AMR.

Identifiers

PMID40395974
PMCPMC12089940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.